Higher CSF rejuvenation composite levels were associated with better cognitive performances and functional status, and lower CSF NfL (n = 43) among individuals with Alzheimer’s disease; these relationships were significantly attenuated in clinically normal adults (Fig. 5; Supplementary Table 3). The gene discussed is NEFL; the disease is Alzheimer disease.